Sarah Albogami
- Health Informatics top 5%
- General Dentistry top 5%
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds 6
- Drug-Induced Hepatotoxicity and Protection 5
- Molecular Medicine top 10%
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 5
-
- Phytochemicals and Antioxidant Activities 7
-
- Computational Drug Discovery Methods 6
-
- Natural Antidiabetic Agents Studies 5
-
- RNA modifications and cancer 5
-
- Essential Oils and Antimicrobial Activity 5
- Co-authors
- Gaber El‐Saber BatihaSaqer S. AlotaibiAhmed M. El‐ShehawiMohammed AlorabiHayder M. Al‐kuraishyAli I. Al‐GareebMohammad M. Al‐SaneaMichel De Waard
- Journals
- SHILAP Revista de lepidopterología (2 papers)Frontiers in Immunology (2 papers)Molecules (9 papers)
- Partner nations
- Saudi ArabiaEgyptIndia
In The Last Decade
Sarah Albogami
95 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Health Informatics 38
- General Dentistry 30
- Pharmacology 128
- Molecular Medicine 53
- Infectious Diseases 181
Countries citing papers authored by Sarah Albogami
This map shows the geographic impact of Sarah Albogami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Albogami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Albogami more than expected).
Fields of papers citing papers by Sarah Albogami
This network shows the impact of papers produced by Sarah Albogami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Albogami. The network helps show where Sarah Albogami may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarah Albogami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2023 | 9 | |
| 3 | 2023 | 13 | |
| 4 | 2022 | 17 | |
| 5 | 2022 | 16 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 16 | |
| 10 | 2022 | 21 | |
| 11 | 2022 | 17 | |
| 12 | 2022 | 27 | |
| 13 | 2022 | 7 | |
| 14 | 2022 | 13 | |
| 15 | 2022 | 10 | |
| 16 | 2022 | 36 | |
| 17 | 2022 | 27 | |
| 18 | 2021 | 3 | |
| 19 | 2021 | 14 | |
| 20 | 2021 | 8 |
About Sarah Albogami
Sarah Albogami is a scholar working on Pharmacology, Complementary and alternative medicine and Biochemistry, having authored 97 papers that have together received 1.5k indexed citations. Recurring topics across this work include Phytochemicals and Antioxidant Activities (7 papers), Pharmacological Effects of Natural Compounds (6 papers), Computational Drug Discovery Methods (6 papers), Natural Antidiabetic Agents Studies (5 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), RNA modifications and cancer (5 papers), COVID-19 Clinical Research Studies (5 papers) and Essential Oils and Antimicrobial Activity (5 papers). The work is most often cited by research in Health Informatics (38 citations), General Dentistry (30 citations) and Pharmacology (128 citations). Sarah Albogami has collaborated with scholars based in Saudi Arabia, Egypt and India. Frequent co-authors include Gaber El‐Saber Batiha, Saqer S. Alotaibi, Ahmed M. El‐Shehawi, Mohammed Alorabi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Mohammad M. Al‐Sanea, Michel De Waard, Eman Fayad and Aziza M. Hassan. Their work appears in journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.